The Australasian Society of Aesthetic Plastic Surgeons (ASAPS) and the Australasian Society of Cosmetic and Procedural Dermatologists (ASCPD) have partnered to provide the aesthetics community with a comprehensive new guide to the complex regulatory framework governing cosmetic injectable practice in Australia.
The reference guide offers a clear and practical overview of current rules surrounding the use of Schedule 4 cosmetic injectables, such as botulinum toxin and dermal fillers. It covers who can prescribe and administer injectables, how products must be stored and labelled, and what’s required for informed consent and patient safety.
Importantly, the guide emphasises that off-label use is allowed only when clinically justified and clearly explained to the patient. It also reminds practitioners of their responsibilities when it comes to advertising, incident reporting and maintaining clinical governance standards.
The document is designed to help practitioners stay compliant and confident in a regulatory environment that continues to evolve. With increased scrutiny on the cosmetic sector, the ASAPS/ASCPD summary is a timely and useful resource for clinics across Australia.
The collaboration between the two societies reflects a unique and longstanding partnership, highlighting both organisations’ shared commitment to practitioner education and patient safety.
Read the full summary here.
